24 Jan Dr. Sambunaris – Publications, Posters, and Press
Academic Publications
Lisdexamfetamine Dimesylate Augmentation for Adults With Major Depressive Disorder and Inadequate Response to Antidepressant Monotherapy: Results from 2 Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Studies —Journal of Affective Disorders, July 5 2016
Effects of levomilnacipran extended-release on motivation/energy and functioning in adults with major depressive disorder — Research Gate, June 2016
Vilazodone in Patients with Generalized Anxiety Disorder —International Clinical Psychopharmacology, August 2015
Vilazodone in patients with generalized anxiety disorder — International Clinical Psychopharmacology, August 2015
Efficacy of levomilnacipran extended-release in improving functional impairment associated with major depressive disorder: Pooled analyses of five double-blind, placebo-controlled trials — International Clinical Psychopharmacology, March 2014
Lisdexamfetamine Dimesylate Augmentation in Adults With Persistent Executive Dysfunction After Partial or Full Remission of Major Depressive Disorder — Neuropsychopharmacology, January 15 2014
Vilazodone in the treatment of major depressive disorder: Efficacy across symptoms and severity of depression — International Clinical Psychopharmacology, November 2013
A Phase III, Double-Blind, Placebo-Controlled, Flexible-Dose Study of Levomilnacipran Extended-Release in Patients With Major Depressive Disorder — Journal of clinical psychopharmacology, October 2013
P.2.b.030 Levomilnacipran SR and functional efficacy in major depressive disorder: pooled analyses of 5 double-blind, placebo-controlled trials — ResearchGate, September 2013
Levomilnacipran ER and Functional Efficacy in Major Depressive Disorder: A Pooled Analyses of 5 Double-Blind, Placebo-Controlled Trials — Psych Congress Network, June 18 2013
A Randomized Controlled Trial of the Efficacy and Safety of Lisdexamfetamine Dimesylate as Augmentation Therapy in Adults With Residual Symptoms of Major Depressive Disorder After Treatment With Escitalopram — The Journal of Clinical Psychiatry, April 26 2013
Lisdexamfetamine Dimesylate Augmentation Effects on Executive Function in Major Depressive Disorder Based on Level of Executive Function Impairment — ResearchGate, April 2013
P.2.a.017 Lisdexamfetamine dimesylate augmentation effects on executive function in major depressive disorder based on depressive symptom levels — ResearchGate, September 2012
An exploratory study of combination buspirone and melatonin SR in Major Depressive Disorder (MDD): A possible role for neurogenesis in drug discovery — Journal of Psychiatric Research, August 10 2012
Efficacy and Safety of Lisdexamfetamine Dimesylate as Augmentation Therapy in Adults With Major Depressive Disorder Treated With an Antidepressant — October 27, 2011
Behavioral pharmacology of serotonin receptor subtypes: Hypotheses for clinical applications of selective ligands — International Review of Psychiatry, July 2009
Clinical Evaluation of the Daily Assessment of Symptoms-Anxiety (DAS-A): A New Instrument to Assess the Onset of Symptomatic Improvement in Generalized Anxiety Disorder — CNS Neuroscience and Therapeutics, February 13 2009
Duloxetine versus escitalopram and placebo in the treatment of patients with major depressive disorder: onset of antidepressant action, a non-inferiority study. — Current Medical Research and Opinion, January 23 2007
Olanzapine/ Fluoxetine Combination for Treatment-Resistant Depression: A Controlled Study of SSRI and Nortriptyline Resistance — Journal of Clinical Psychiatry, October 2005
Development of new antidepressants — Journal of Clinical Psychiatry, 1997
Schizophrenia and Manic-Depressive Disorder: The Biological Roots of Mental Illness as Revealed by the Landmark Study of Identical Twins — Basic Books, 1995
Stroke-Related Aphasias Mistaken for Psychotic Speech: Two Case Reports — Journal of Geriatric Psychiatry and Neurology, September 1994
In the News
Trek Medical Receives 2016 Best of Alpharetta Award — PRLOG, July 19 2016
Using Your Brain to Fight Depression — PRLOG, June 7 2016
Depression and Botox: Clinical Research Trials Show Promise — PRLOG, May 31 2016
The Stigma of Brain Health — Herald Newspapers, April 20 2016
Opiates for Self-Medication Part 1 — Herald Newspapers, April 19 2016
Opiates for Self-Medication Part 2 — Herald Newspapers, April 19 2016
Brain Health and Wellness — Herald Newspapers, March 3 2016
The Institute for Advanced Medical Research Partners with Global Medical Education to Host Psychiatry Update in Atlanta — Prweb, February 18 2016
Dr. Angelo Sambunaris to Be Featured on Atlanta’s CW affiliate WUPA — Roswell Patch, October 6 2015
Dr. Angelo Sambunaris to Be Featured on Atlanta’s CW affiliate WUPA — Alpharetta-Milton Patch, October 6 2015
Dr. Angelo Sambunaris to Be Featured on Atlanta’s CW Affiliate WUPA — PRLOG, October 6 2015
Alzheimer’s Disease: What Does the Future hold? — Guardian Pharmacy, Septermber 29 2015
Botox for Depression — Atlanta Best-Self Magazine, September 28 2015
Faculty Members — U.S. Psychiatric and Mental Health Congress, September 10 2015
Trek Medical Brings Outpatient Addiction Services to North Fulton — Roswell Patch, September 4 2015
Trek Medical Brings Outpatient Addiction Services to North Fulton — PRLOG, September 2 2015
Knowledge Series explores breakthroughs in Alzheimer’s — Inside the Gates, August 23 2015
The Connection Between Your Gut and Your Brain — Hubpages, July 6 2015
Childhood and Teenage Depression – What Parents Should Know — HubPages, June 3 2015
Aging, Depression and Anxiety — Atlanta Best-Self Magazine, May 27 2015
Adolescent ADHD – What Parents Should Know — HubPages, May 19 2015
Milton to Host Free Seminar on Alzheimer’s Disease — Alpharetta-Milton Patch, May 7 2015
Fibromyalgia and Nutrition: Is There a Link? — Hubpages, April 23 2015
Alzheimer’s Disease – What Everyone Should Know About This Killer — HubPages, April 3 2015
Concerns About Participating in a Clinical Trial — HubPages, March 19 2015
Anxiety: When it’s more than worry, what can you do? — Best Self Magazine, March 2015
Depression: Teenage Anxiety or Depression? — Atlanta Best-Self Magazine, February 20 2015
Anxiety in Teens and Adults — Atlanta Best-Self Magazine, February 19 2015
Alzheimer’s Disease Update — Alpharetta-Milton Patch, February 3 2015
Institute for Advanced Medical Research Partners with the City of Milton to offer Alzheimer’s Disease Update — Prweb, February 3 2015
Milton to Host Symposium on Alzheimer’s Disease — Alpharetta-Milton Patch, January 29 2015
Adult/Teen Depression Clinical Trial — Alpharetta-Milton Patch, January 27 2015
The Institute for Advanced Medical Research Partners with Global Medical Education to Host Psychiatry Update in Atlanta — Prweb, January 20 2015
Don’t Let Your ADHD Define You — Atlanta Best-Self Magazine, December 23 2014
Free Seminar: Coping with Holiday Depression — Alpharetta-Milton Patch, December 10 2014
Depression Drug Shows Promise for Future, Study Reports — Prweb, November 25 2014
Alzheimer’s Disease: Researching Tomorrow’s Treatments — Atlanta Best-Self Magazine, November 24 2014
Fibromyalgia Clinical Study to be Launched in North Atlanta — Alpharetta-Milton Patch, November 19 2014
Bringing a Loved One with Dementia Home for the Holidays — Alpharetta-Milton Patch, November 19 2014
Finding a Better Way to Treat Depression Local Clinical Research Study Explores Promising New Method — Alpharetta-Milton Patch, November 13 2014
Clinical Medical Research Facility Opens in Alpharetta — Alpharetta-Milton Patch, November 5 2014
The Institute for Advanced Medical Research launches Fibromyalgia study — ME/CFS Australia (SA) Inc., October 23 2014
Prakash Masand, M.D., appointed Chief Scientific Officer at Institute for Advanced Medical Research — Alpharetta-Milton Patch, October 8 2014
Prakash Masand, M.D., Appointed Chief Scientific Officer at Institute for Advanced Medical Research — Prweb, October 7 2014
Institute for Advanced Medical Research Presents Alzheimer’s Disease Seminar — Prweb, September 23 2014
Sandy Springs Medical Research Company Moves to Alpharetta — Sandy Springs Patch, September 10 2014
American Psychiatric Association – 2014 — News 4 Med, May 7 2014
Forest Laboratories, Inc. to Present Data about Levomilnacipran and Vilazodone at the American Psychiatric Association 167th Annual Meeting — Forest Laboratories, Inc., May 2 2014
Wanted: Volunteers to Assist in Alzheimer’s Research! Dr. Angelo Sambunaris — Griswold Home Care, April 30 2014
Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting — Shire, May 17 2013
7/15/12: Dr. Angelo Sambunaris — The Weekly Check Up, July 15 2012
The Placebo Prescription — The New York Times, January 9 2000
Atlanta’s Strong STARTS Program Helps Educators Reach Troubled Kids — Psychiatric Times, March 1 1998